Skip to main
CTRE

CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT (CTRE) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 67%
Hold 11%
Sell 0%
Strong Sell 0%

Bulls say

CareTrust REIT is well-positioned to be a long-term, attractive investment considering its experienced management team, focus on investing in high-demand healthcare properties, and strong financials with a low leverage profile and ample liquidity. Despite slightly reducing estimates for investment timing and higher expenses, the company has a large pipeline of potential deals, particularly in the UK, and an attractive outlook for 2026. With a low leverage profile and potential for equity funding, CareTrust REIT has the ability to continue growing and generating stable cash flow from its triple-net lease arrangements and financing receivable investments.

Bears say

CareTrust REIT is a self-administered REIT with a strong balance sheet and plenty of liquidity, but its stock could decline in the face of tightening reimbursement rates and potential issues with new tenants or the highly competitive investment market. The company's structured finance portfolio, which has seen significant growth in recent years, could also pose potential risks in the long term.

CareTrust REIT (CTRE) has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 67% recommend Buy, 11% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CareTrust REIT (CTRE) Forecast

Analysts have given CareTrust REIT (CTRE) a Buy based on their latest research and market trends.

According to 9 analysts, CareTrust REIT (CTRE) has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $43.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $43.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CareTrust REIT (CTRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.